Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Clinical Trials

Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Explore clinical trials studying Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer trial results

Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

NCT04546009

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, +4 more
Locations: Orange Coast Memorial Medical Center Fountain Valley, California, United States

Long Beach Memorial Medical Center Long Beach, California, United States

Kaiser Permanente - San Leandro Medical Center San Leandro, California, United States

Stanford Univ Medical Center Stanford, California, United States

View all 256 locations

View Trial Details

Related conditions